Skip to content
News
We invest in growth stage diagnostic companies and empower them with the full strength of our collective resources, capital, and expertise.
October 11, 2025
Satio completes development, testing of remotely controllable, at-home intradermal drug delivery system
READ MORE
July 2, 2025
Sapphiros Secures Additional NIH RADx® Support to Advance Next-Gen Molecular Respiratory At-Home Diagnostic
READ MORE
August 6, 2024
Sapphiros Appoints Healthcare Executive Jackson McAdam as Chief Financial Officer
READ MORE
May 30, 2024
Sapphiros Launches NowFuture™: A New Era in Personalized Wellness
READ MORE
January 4, 2024
Sapphiros Is Pleased To Announce OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests In Sapphiros
READ MORE
November 22, 2023
Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement
READ MORE
About Sapphiros
Meet Our Team
Our Companies
News
Contact Us
About Sapphiros
Meet Our Team
Our Companies
News
Contact Us